Skip to main content

Table 2 TNM staging and tumor grading

From: TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study

T (TNM)

 T1

53.68% (73/136)

 T2

36.03% (49/136)

 T3

5.88% (8/136)

 T4

4.41% (6/136)

N (TNM)

 N0

37.5% (51/136)

 N1

36.03% (49/136)

 N2

11.76% (16/136)

 N3

14.71% (20/136)

TNM stage

 I

34.56% (47/136)

 II

36.03% (49/136)

 III

24.26% (33/136)

 IV

5.15% (7/136)

Tumor grading

 G1

7.35% (10/136)

 G2

52.21% (71/136)

 G3

40.44% (55/136)

  1. Acronyms: TNMtumor node metastasis